Rob Medcalf Is Working On a Novel Thrombolytic Drug
Monash Translational Medicine shared on LinkedIn:
”Time is brain’ when a person has a stroke.
But even when a patient receives medical attention within 60 minutes, that’s often not enough: tPA, the main drug currently used to treat acute ischemic stroke (the most common stroke type in Australia) isn’t effective for the majority of patients.
Professor Rob Medcalf, of the Australian Centre for Blood Diseases based at Monash Translational Medicine, is working on a novel thrombolytic (clot-busting) drug that could give many more stroke patients a better chance of recovery.
He’s been awarded two Monash University grants – from the Monash Research Impact Fund (MIRF) and the MNHS Commercialisation Incubator Program (MCIP) – to progress development of the drug.
”We desperately need more drug options to treat stroke, for the many patients who can’t go on TPA for reasons ranging from the other medications they’re on, to the short window for effective treatment,” Rob says.
‘These grants will help us address some of the challenges of bringing new drugs to market.”’
-
Apr 20, 2026, 18:59Chokri Ben Lamine: Contributing to a Landmark Chapter on Amegakaryocytic Thrombocytopenia in Bone Marrow Failure
-
Apr 20, 2026, 18:39David McIntosh: A Watershed Moment for Global Plasma Community and Call for Unified Action
-
Apr 20, 2026, 18:15Nandini Pethe: Grateful for a Fantastic 2026 HFA Symposium Filled with Impactful Educational Sessions and Meaningful Connections
-
Apr 20, 2026, 17:13Armghan Ans: The Stroke Decision Nobody Owns
-
Apr 20, 2026, 17:12Assefa Desalew: RhD-Negative Status and Adverse Perinatal Outcomes in Eastern Ethiopia
-
Apr 20, 2026, 16:55Francesco Lo Monaco: Blood Type and Heart Risk – Small Differences, Bigger Role of Lifestyle
-
Apr 20, 2026, 16:44Supporting the Next Generation in Thrombosis and Hemostasis at ISTH 2026
-
Apr 20, 2026, 16:38Bjorn Logi Thorarinsson: Strengthening Stroke Units Through Certification, Registries, and Evidence-Based Practice
-
Apr 20, 2026, 16:37Domenico Girelli: Anemia Is Linked to Higher Dementia Risk and Elevated Alzheimer’s Disease Biomarkers